The uncommon causes of status epilepticus: A Systematic Review

Epilepsy Research

Volumn 91, Issue 2-3, 2010, Pages 111-122

  Tan, R Y L ^a   Neligan, A ^a   Shorvon, S D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Status epilepticus; Uncommon causes

Indexed keywords

AMPA RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CEFAZOLIN; DNA DIRECTED DNA POLYMERASE GAMMA; DOMOIC ACID; ETIRACETAM; IFOSFAMIDE; ISONIAZID; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYTOIN; STEROID; TIAGABINE; VALPROIC ACID;

ACUTE KIDNEY FAILURE; AMNESIA; ATAXIA; CAT SCRATCH DISEASE; CLINICAL TRIAL; COMA; CREUTZFELDT JAKOB DISEASE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENCEPHALITIS; EPILEPTIC STATE; FEVER; GENE MUTATION; HAPPY PUPPET SYNDROME; HASHIMOTO ENCEPHALOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; MELAS SYNDROME; METABOLIC ACIDOSIS; NAUSEA; PARANEOPLASTIC ENCEPHALITIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PORPHYRIA; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; RASH; RECOMMENDED DRUG DOSE; REVIEW; RING CHROMOSOME; RING CHROMOSOME 20; SEIZURE; SYSTEMATIC REVIEW; TACHYCARDIA; VOMITING;

ANIMALS; COMMUNICABLE DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; PHARMACEUTICAL PREPARATIONS; STATUS EPILEPTICUS;

EID: 77957018697     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.07.015     Document Type: Review

References (137)

1. Alemdar M., Iseri P., Selekler M., Budak F., Demirci A., Komsuoglu S.S. MELAS presented with status epilepticus and Anton-Babinski syndrome; value of ADC mapping in MELAS. J. Neuropsychiatry Clin. Neurosci. 2007, 19:482-483.
2. Al-Ansari M., Todwal A. A 20-year-old man with status epilepticus and uncontrolled hypertension. Chest 2007, 131:309-312.
3. Armengol C.E., Hendley J.O. Cat-scratch disease encephalopathy: a cause of status epilepticus in school-aged children. J. Pediatr. 1999, 134:635-638.
4. Ashkenasi A., Amir J., Cohen H.A., Frydman M., Varsano I., Lahat E. Status epilepticus encephalopathy with cat-scratch disease. Clin. Pediatr. (Phila) 1993, 32:701-702.
5. Bahi-Buisson N., Kaminska A., Nabbout R., Barnerias C., Desguerre I., de Lonlay P., Mayer M., Plouin P., Dulac O., Chiron C. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 2006, 47:380-386.
6. Bartolomei F., Gavaret M., Dhiver C., Gastaut J.A., Gambarelli D., Figarell-Branger D., Gastaut J.L. Isolated, chronic, epilepsia partialis continua in an HIV-infected patient. Arch. Neurol. 1999, 56:111-114.
7. Battaglia A., Carey J.C., Cederholm P., Viskochil D.H., Brothman A.R., Galasso C. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999, 103:830-836.
8. Beauvais K., Cave-Riant F., De Barace C., Tardieu M., Tournier-Lasserve E., Furby A. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol. 2004, 52:58-61.
9. Bellesi M., Passamonti L., Silvestrini M., Bartolini M., Provinciali L. Non-convulsive status epilepticus during lithium treatment at therapeutic doses. Neurol. Sci. 2006, 26:444-446.
10. Berciano J., Leno C., Figols J., Garcia A., Polo J.M., Berciano M.T., Ariza A. Epilepsia partialis continua in progressive multifocal leukoencephalopathy: a motor cortex isolation syndrome. Mov. Disord. 2003, 18:1559-1564.
11. Bhatia R., Vibha D., Srivastava M.V.P., Prasad K., Tripathi M., Singh M.B. Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria. Epilepsia 2008, 49:934-936.
12. Biraben A., Semah F., Ribeiro M.J., Douaud G., Remy P., Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 2004, 63:73-77.
13. Blum A.S., Drislane F.W. Nonconvulsive status epilepticus in thrombotic thrombocytopenic purpura. Neurology 1996, 47:1079-1081.
14. Bosanko C.M., Gilroy J., Wang A.M., Sanders W., Dulai M., Wilson J., Blum K. West nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch. Neurol. 2003, 60:1448-1452.
15. Buoni S., Orrico A., Galli L., Zannolli R., Burroni L., Hayek J., Fois A., Sorrentino V. SCN1A (2528delG) novel truncating mutation with benign outcome of severe myoclonic epilepsy of infancy. Neurology 2006, 66:606-607.
16. Burneo J.G., Steven D., McLachlan R.S. Nonconvulsive status epilepticus after temporal lobectomy. Epilepsia 2005, 46:1325-1327.
17. Caksen H., Odabas D., Erol M., Anlar O., Tuncer O., Atas B. Do not overlook acute isoniazid poisoning in children with status epilepticus. J. Child Neurol. 2003, 18:142-143.
18. Capocchi G., Balducci A., Cecconi M., Pelli M.A., Picchiarelli A., Silvestrelli G., Zampolini M. Valproate-induced epileptic tonic status. Seizure 1998, 7:237-241.
19. Capovilla G., Paladin F., Bernardina B.D. Rasmussen's syndrome: longitudinal EEG study from the first seizure to epilepsia partialis continua. Epilepsia 1997, 4:483-488.
20. Carithers H.A., Margileth A.M. Cat-scratch disease-acute encephalopathy and other neurologic manifestations. Am. J. Dis. Child. 1991, 145:98-101.
21. Carolino R.O.G., Beleboni R.O., Pizzo A.B., Vecchio F.D., Garcia-Cairasco N., Moyses-Neto M., dos Santos W.F., Coutinho-Netto J. Convulsant activity and neurochemical alterations induced by a fraction obtained from fruit Averrhoa carambola (Oxalidaceae: Geraniales). Neurochem. Int. 2005, 46:523-531.
22. Cendes F., Andermann F., Carpenter S., Zatorre R.J., Cashman N.R. Temporal-lobe epilepsy caused by domoic acid intoxication-evidence for glutamate receptor-mediated excitotoxicity in humans. Ann. Neurol. 1995, 37:123-126.
23. Chan P.K.Y., Yung W.H. Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake. Brain Res. 1999, 838:18-26.
24. Chang J.M., Hwang S.J., Kuo H.T., Tsai J.C., Guh J.Y., Chen H.C., Tsai J.H., Lai Y.H. Fatal outcome after ingestion of star fruit (Averrhoa carambola) in uremic patients. Am. J. Kidney Dis. 2000, 35:189-193.
25. Chatellier D., Jourdain M., Mangalaboyi J., Ader F., Chopin C., Derambure P., Fourrier F. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med. 2002, 28:214-217.
26. Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006, 368:222-229.
27. Chin R.F., Neville B.G., Scott R.C. A systematic review of the epidemiology of status epilepticus. Eur. J. Neurol. 2004, 11:800-810.
28. Choi J.Y., Seok H.Y., Lee S.H., Kim B.J., Park K.W., Jung K.Y. Epidural adhesiolysis complicated by cefazolin-induced status epilepticus: two cases. Clin. Neurol. Neurosurg. 2008, 110:1041-1043.
29. Cock H. The role of mitochondria in status epilepticus. Epilepsia 2007, 48:24-27.
30. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology 2000, 55:693-697.
31. Cokgor I., Rozear M., Morgenlander J.C. Seizures and Creutzfeldt-Jakob disease. A case report and series review. N. C. Med. J. 1999, 60:108-109.
32. Crimmins D., Morris J.G.L., Walker G.L., Sue C.M., Byrne E., Stevens S., Jeanfrancis B., Yiannikas C., Pamphlett R. Mitochondrial encephalomyopathy-variable clinical expression within a single kindred. J. Neurol. Neurosurg. Psychiatry 1993, 56:900-905.
33. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X.Y., Lai M.Z., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-1098.
34. Debonnel G., Beauchesne L., Demontigny C. Domoic acid, the alleged mussel toxin, might produce its neurotoxic effect through kainate receptor activation-an electrophysiological study in the rat dorsal hippocampus. Can. J. Physiol. Pharmacol. 1989, 67:29-33.
35. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
36. De Sarro A., Ammendola D., Zappala M., Grasso S., De Sarro G.B. Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob. Agents Chemother. 1995, 39:232-237.
37. Elia M., Musumeci S.A., Ferri R., Colamaria V., Azan G., Greco D., Stefanini M.C. Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continua. Brain Dev. 1996, 18:207-211.
38. Engelsen B.A., Tzoulis C., Karlsen B., Lillebo A., Laegreid L.M., Aasly J., Zeviani M., Bindoff L.A. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 2008, 131:818-828.
39. Emery D.P., Corban J.G. Camphor toxicity. J. Paediatr. Child Health 1999, 35(1):105-106.
40. Erol I., Alehan F., Yalcin K. Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child. J. Child Neurol. 2006, 21:820-822.
41. Fauser S., Huppertz H.J., Bast T., Strobl K., Pantazis G., Altenmueller D.M., Feil B., Rona S., Kurth C., Rating D., Korinthenberg R., Steinhoff B.J., Volk B., Schulze-Bonhage A. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 2006, 129:1907-1916.
42. Feddersen B., Bender A., Arnold S., Klopstock T., Noachtar S. Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS. Neurology 2003, 61:1149-1150.
43. Ferlazzo E., Raffaele M., Mazzu H., Pisani F. Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy. Epilepsy Behav. 2006, 8:328-330.
44. Ferrari S., Monaco S., Morbin M., Zanusso G., Bertolasi L., Cerini R., Rizzuto N. HIV-associated PML presenting as epilepsia partialis continua. J. Neurol. Sci. 1998, 161:180-184.
45. Franca M.C., de C.R., Balthazar M.L., Faria A.V., Cendes F. Focal status epilepticus as the first manifestation of paracoccidioidomycosis. Eur. J. Neurol. 2005, 12:73-74.
46. Galvan-Manso M., Campistol J., Conill J., Sanmarti F.X. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome. Epileptic Disord. 2005, 7:19-25.
47. Goral S., Anderson B., Hager C., Edwards K.M. Detection of Rochalimaea-Henselae DNA by polymerase chain-reaction from suppurative nodes of children with cat-scratch disease. Pediatr. Infect. Dis. J. 1994, 13:994-997.
48. Goto Y., Nonaka I., Horai S. A mutation in the transfer Rnaleu(Uur) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
49. Grimmett W.G., Dzendolet I., Whyte I. Intravenous thiodan (30% endosulfan in xylene). J. Toxicol. Clin. Toxicol. 1996, 34:447-452.
50. Gürses C., Kürtüncü M., Jirsch J., Yesilot N., Hanaĝasi H., Bebek N., Baykan B., Emre M., Gökyiĝit A., Andermann F. Neurosyphilis presenting with status epilepticus. Epileptic Disord. 2007, 9:51-56.
51. Hadley S., Albrecht M.A., Tarsy D. Cat-scratch encephalopathy: a cause of status epilepticus and coma in a healthy young adult. Neurology 1995, 45:196.
52. Hahn J.S., Sum J.M., Lee K.P. Unusual MRI findings after status epilepticus due to cat-scratch disease. Pediatr. Neurol. 1994, 10:255-258.
53. Hesdorffer D.C., Logroscino G., Cascino G., Annegers J.F., Hauser W.A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998, 50:735-741.
54. Hess D.C., Sethi K.D. Epilepsia partialis continua in multiple sclerosis. Int. J. Neurosci. 1990, 50:109-111.
55. Hong Y.H., Lee C.K. A case of adult onset Still's disease with systemic inflammatory response syndrome complicated by fatal status epilepticus. Rheumatol. Int. 2008, 28:931-933.
56. Huang C.C., Kuo H.C., Chu C.C., Liou C.W., Ma Y.S., Wei Y.H. Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J. Biomed. Sci. 2002, 9:527-533.
57. Inoue Y., Fujiwara T., Matsuda K., Kubota H., Tanaka M., Yagi K., Yamamori K., Takahashi Y. Ring chromosome 20 and nonconvulsive status epilepticus-a new epileptic syndrome. Brain 1997, 120:939-953.
58. Jacobs J., Bernard G., Andermann E., Dubeau F., Andermann F. Refractory and lethal status epilepticus in a patient with ring chromosome 20 syndrome. Epileptic Disord. 2008, 10:254-259.
59. Janes S.E., Santosh B., Thomas D., Vyas H. Hashimoto's encephalopathy: an unusual cause of seizures in the intensive care unit. Pediatr. Crit. Care Med. 2004, 5:578-581.
60. Jeffery K.J., Ellis S.J., Fink C.G. Non-convulsive status epilepticus as a complication of Mycoplasma pneumoniae infection. Br. J. Clin. Pract. 1995, 49:155-156.
61. Jette N., Cappell J., VanPassel L., Akman C.I. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy. Neurology 2006, 67:1514-1515.
62. Kanter I.C., Huttner H.B., Staykov D., Biermann T., Struffert T., Kerling F., Hilz M.J., Schellinger P.D., Schwab S., Bardutzky J. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008, 49:914-920.
63. Kellinghaus C., Dziewas R., Ludemann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 2002, 11:243-249.
64. Keranen T., Kuusisto H. NARP syndrome and adult-onset generalised seizures. Epileptic. Disord. 2006, 8:200-203.
65. Kinirons P., O'Dwyer J.P., Connolly S., Hutchinson M. Paraneoplastic limbic encephalitis presenting as lingual epilepsia partialis continua. J. Neurol. 2006, 253:256-257.
66. Knake S., Rosenow F., Vescovi M., Oertel W.H., Mueller H.H., Wirbatz A., Katsarou N., Hamer H.M. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714-718.
67. Koepp M.J., Edwards M., Collins J., Farrel F., Smith S. Status epilepticus and tiagabine therapy revisited. Epilepsia 2005, 46:1625-1632.
68. Koide R., Shimizu T., Koike K., Dalmau J. EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J. Neurooncol. 2007, 81:71-74.
69. Krieger A.C., Takeyasu M. Nonconvulsive status epilepticus in theophylline toxicity. J. Toxicol. Clin. Toxicol. 1999, 37:99-101.
70. Kumada S., Kubota M., Hayashi M., Uchiyama A., Kurata K., Kagamihara Y. Fixation-sensitive myoclonus in Lafora disease. Neurology 2006, 66:1574-1576.
71. Laan L.A.E.M., Renier W.O., Arts W.F.M., Buntinx I.M., van der Burgt I.J.A.M., Stroink H., Beuten J., Zwinderman K.H., van Dijk J.G., Brouwer O.F. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia 1997, 38:195-199.
72. Lee K.C., Garcia P.A., Alldredge B.K. Clinical features of status epilepticus in patients with HIV infection. Neurology 2005, 65:314-316.
73. Leff A.P., Mcnabb A.W., Hanna M.G., Clarke C.R.A., Larner A.J. Complex partial status epilepticus in late-onset MELAS. Epilepsia 1998, 39:438-441.
74. Leikin J.B., Benigno J., Dubow J.S., Fisher M. Status epilepticus due to tiagabine ingestion. Am. J. Ther. 2008, 15:290-291.
75. Liou C.W., Huang C.C., Tsai J.L., Liu J.Y., Pang C.Y., Lee H.C., Wang E.K., Wei Y.H. Absence of maternal A3243G mtDNA mutation and reversible hyperglycemia in a patient with MELAS syndrome. Acta Neurol. Scand. 2000, 101:65-69.
76. LoVecchio F. Neurosyphilis presenting as refractory status epilepticus. Am. J. Emerg. Med. 1995, 13:685-686.
77. Marini C., Parmeggiani L., Masi G., D'Arcangelo G., Guerrini R. Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. J. Child Neurol. 2005, 20:693-696.
78. Martinez-Rodriguez J.E., Barriga F.J., Santamaria J., Iranzo A., Pareja J.A., Revilla M., dela Rosa C.R. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am. J. Med. 2001, 111:115-119.
79. Morazin F., Lumbroso A., Harry P., Blaise M., Turcant A., Montravers P., Gauzit R. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin. Toxicol. (Phila) 2007, 45:794-797.
80. Nakamura S., Yoshinari M., Wakisaka M., Kodera H., Doi Y., Yoshizumi H., Asano T., Iwase M., Mihara F., Fujishima M. Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetes Metab. 2000, 26:407-410.
81. Narkewicz M.R., Sokol R.J., Beckwith B., Sondheimer J., Silverman A. Liver involvement in Alpers disease. J. Pediatr. 1991, 119:260-267.
82. Naviaux R.K., Nguyen K.V. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann. Neurol. 2005, 58:491.
83. Neligan, A., Shorvon, S.D., 2010. The frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch. Neurol. 67, in press.
84. Neto M.M., da Costa J.A.C., Garcia-Cairasco N., Netto J.C., Nakagawa B., Dantas M. Intoxication by star fruit (Averrhoa carambola) in 32 uraemic patients: treatment and outcome. Nephrol. Dial. Transplant. 2003, 18:120-125.
85. Neufeld M.Y., Talianski-Aronov A., Soffer D., Korczyn A.D. Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease. Seizure 2003, 12:403-405.
86. Nguyen K.V., Ostergaard E., Ravn S.H., Balslev T., Danielsen E.R., Vardag A., McKiernan P.J., Gray G., Naviaux R.K. POLG mutations in Alpers syndrome. Neurology 2005, 65:1493-1495.
87. Nicolao P., Giometto B. Neurological toxicity of ifosfamide. Oncology 2003, 65:11-16.
88. Ohtsuka Y., Kobayashi K., Yoshinaga H., Ogino T., Ohmori L., Ogawa K., Oka E. Relationship between severity of epilepsy and developmental outcome in Angelman syndrome. Brain Dev. 2005, 27:95-100.
89. Ozturk S., Kocabay G., Topcular B., Yazici H., Cagatay A.A., Bahat G., Baykan B., Turkmen A., Yildiz A. Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure. Clin. Exp. Nephrol. 2009, 13:138-144.
90. Parry J., Tuch P., Knezevic W., Fabian V. Creutzfeldt-Jakob syndrome presenting as epilepsia partialis continua. J. Clin. Neurosci. 2001, 8:266-268.
91. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. 2004, 37:1951-1962.
92. Perl T.M., Bedard L., Kosatsky T., Hockin J.C., Todd E.C.D., Remis R.S. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N. Engl. J. Med. 1990, 322:1775-1780.
93. Peterus T., Huang K.M., Chi E.Y., Shih C.C., Su M.L., Huang J.S. Koshevnikov syndrome in a patient with MELAS plus syndrome: electron microscopic and neuroimage studies. Chin. Med. J. 1997, 110:726-730.
94. Povlsen U.J., Wildschiodtz G., Hogenhaven H., Bolwig T.G. Nonconvulsive status epilepticus after electroconvulsive therapy. J. ECT 2003, 19:164-169.
95. Primavera A., Audenino D., Cocito L. Ifosfamide encephalopathy and nonconvulsive status epilepticus. Can. J. Neurol. Sci. 2002, 29:180-183.
96. Quilliam M.A., Wright J.L.C. The amnesic shellfish poisoning mystery. Anal. Chem. 1989, 61:1053A-1106A.
97. Ravid S., Shahar E., Genizi J., Schahor Y., Kassis I. Acute Q fever in children presenting with encephalitis. Pediatr. Neurol. 2008, 38:44-46.
98. Rees J.H., Smith S.J., Kullmann D.M., Hirsch N.P., Howard R.S. Creutzfeldt-Jakob disease presenting as complex partial status epilepticus: a report of two cases. J. Neurol. Neurosurg. Psychiatry 1999, 66:406-407.
99. Rossetti A.O., Dunand M. Creutzfeldt-Jakob disease: evolution from nonconvulsive status epilepticus, through SIRPIDs, to generalized periodic discharges. Clin. Neurophysiol. 2007, 118:2533-2536.
100. Rossetti A.O., Hurwitz S., Logroscino G., Bromfield E.B. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J. Neurol. Neurosurg. Psychiatry 2006, 77:611-615.
101. Rydel J.J., Rodby R.A. An 18-year-old man with Goodpasture's syndrome and ANCA-negative central nervous system vasculitis. Am. J. Kidney Dis. 1998, 31:345-349.
102. Saltuari L., Marosi M.J., Kofler M., Bauer G. Status epilepticus complicating intrathecal baclofen overdose. Lancet 1992, 339:373-374.
103. Samarasekera S.R., Vincent A., Welch J.L., Jackson M., Nichols P., Griffiths T.D. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J. Neurol. Neurosurg. Psychiatry 2007, 78:391-394.
104. Shahar E., Andraus J., Sagie-Lerman T., Savitzki D. Valproic acid therapy inducing absence status evolving into generalized seizures. Pediatr. Neurol. 2002, 26:402-404.
105. Sharma P., Gupta R.C., Bhardwaja B., Mathur A.K. Status epilepticus and death following acute carbamazepine poisoning. J. Assoc. Phys. India 1992, 40:561-562.
106. Shavit Y.B., Graus F., Probst A., Rene R., Steck A.J. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann. Neurol. 1999, 45:255-258.
107. Shinnar S., Berg A.T., Treiman D.M., Hauser W.A., Hesdorffer D.C., Sackellares J.C., Leppik I., Sillanpaa M., Sommerville K.W. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia 2001, 42:372-379.
108. Sitburana O., Witoonpanich R., Phudhichareonrat S., Lertrit P., Supavilai R. Seizures in myoclonic epilepsy with ragged-red fibers detected by DNA analysis: a case report. J. Med. Assoc. Thai. 2001, 84:1051-1055.
109. Striano P., Pagliuca M., Andreone V., Zara F., Coppola A., Striano S. Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. J. Neurol. 2006, 253:248-249.
110. Sugimoto T., Yasuhara A., Ohta T., Nishida N., Saitoh S., Hamabe J., Niikawa N. Angelman syndrome in three siblings: characteristic epileptic seizures and EEG abnormalities. Epilepsia 1992, 33:1078-1082.
111. Tahta K., Ozgen T., Berker M., Ciger A. Status epilepticus following iohexol myelography. Neuroradiology 1993, 35:322-323.
112. Tajender V., Saluja J. INH induced status epilepticus: response to pyridoxine. Indian J. Chest Dis. Allied Sci. 2006, 48:205-206.
113. Teitelbaum J.S., Zatorre R.J., Carpenter S., Gendron D., Evans A.C., Gjedde A., Cashman N.R. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 1990, 322:1781-1787.
114. Tibussek D., Mayatepek E., Distelmaier F., Rosenbaum T. Status epilepticus due to attempted suicide with isoniazid. Eur. J. Pediatr. 2006, 165:136-137.
115. Tsai M.H., Lee L.H., Chen S.D., Lu C.H., Chen M.T., Chuang Y.C. Complex partial status epitepticus as a manifestation of Hashimoto's encephatopathy. Seizure 2007, 16:713-716.
116. Tsuji M., Tanaka H., Yamakawa M., Sagawa R., Azuma H. A case of systemic lupus erythematosus with complex partial status epilepticus. Epileptic Disord. 2005, 7:249-251.
117. Turk-Boru U., Kocer A., Alp R., Gumus M., Gumus M. Status epilepticus in a case with wilson's disease during D-pencillamine treatment. Swiss Med. Wkly. 2003, 133:446-447.
118. Tzoulis C., Engelsen B.A., Telstad W., Aasly J., Zeviani M., Winterthun S., Ferrari G., Aarseth J.H., Bindoff L.A. The spectrum of clinical disease caused by the A467T and W748SPOLG mutations: a study of 26 cases. Brain 2006, 129:1685-1692.
119. Uemura N., Matsumoto A., Nakamura M., Watanabe K., Negoro T., Kumagai T., Miura K., Ohki T., Mizuno S., Okumura A., Aso K., Hayakawa F., Kondo Y. Evolution of seizures and electroencephalographical findings in 23 cases of deletion type Angelman syndrome. Brain Dev. 2005, 27:383-388.
120. Valente K.D., Koiffmann C.P., Fridman C., Varella M., Kok F., Andrade J.Q., Grossmann R.M., Marques-Dias M.J. Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13. Arch. Neurol. 2006, 63:122-128.
121. Van Paesschen W., Bodian C., Maker H. Metabolic abnormalities and new-onset seizures in human immunodeficiency virus-seropositive patients. Epilepsia 1995, 36:146-150.
122. Vignatelli L., Tonon C., D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003, 44:964-968.
123. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., Clover L., Parkinson A., Bien C.G., Omer S., Lang B., Rossor M.N., Palace J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
124. Vinton A., Kornberg A.J., Cowley M., Matkovic Z., Kilpatrick C., O'Brien T.J. Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy. J. Clin. Neurosci. 2005, 12:128-133.
125. Vollmar C., Noachtar S. Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient. Neurology 2007, 68:310.
126. Wallace K.L. Antibiotic-induced convulsions. Crit. Care Clin. 1997, 13:741-762.
127. Wasterlain C.G., Chen J.W. Definition and classification of status epilepticus. Status Epilepticus: Mechanisms and Management 2006, 11-16. The MIT Press, Cambridge, MA. 1st edn. C.G. Wasterlain, D.M. Treiman (Eds.).
128. Weimer T., Boling W., Pryputniewicz D., Palade A. Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis. J. Neurosurg. 2008, 109:742-745.
129. Wengs W.J., Talwar D., Bernard J. Ifosfamide-induced nonconvulsive status epilepticus. Arch. Neurol. 1993, 50:1104-1105.
130. Wong M.C., Suite N.D.A., Labar D.R. Seizures in human-immunodeficiency-virus infection. Arch. Neurol. 1990, 47:640-642.
131. Wong M.C., Suite N.D.A., Labar D.R. Nonconvulsive generalized status epilepticus and aids. Ann. Intern. Med. 1992, 116:171-172.
132. Wood J.D., Peesker S.J. Correlation between changes in gaba metabolism and isonicotinic acid hydrazide-induced seizures. Brain Res. 1972, 45:489.
133. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002, 58:1070-1076.
134. Yagupsky P., Sofer S. Cat-scratch encephalopathy presenting as status epilepticus and lymphadenitis. Pediatr. Emerg. Care 1990, 6:43-45.
135. Yang Y.W., Tsai C.H., Chang F.C., Lu M.K., Chiu P.Y. Reversible paraneoplastic limbic encephalitis caused by a benign ovarian teratoma: report of a case and review of literatures. J. Neurooncol. 2006, 80:309-312.
136. Yoshino A., Yoshimasu H., Tatsuzawa Y., Asakura T., Hara T. Nonconvulsive status epilepticus in two patients with neuroleptic malignant syndrome. J. Clin. Psychopharmacol. 1998, 18:347-349.
137. Zaatreh M.M. Levetiracetam in porphyric status epilepticus-a case report. Clin. Neuropharmacol. 2005, 28:243-244.